Insiders · Profile

SANDERS MACHELLE

Director at Fortrea · Director at BIOCRYST PHARMACEUTICALS. Filing since 15 Jun 2023. CIK 0001718020

FTRE Fortrea Holdings Inc. Director · 1 trade BCRX BIOCRYST PHARMACEUTICALS INC Director · 3 trades

Company

Date

Role

Action

Shares

Amount

Of holding

FTRE Fortrea Holdings Inc.

3 Aug 2026

Director

Sold at will

9,700

$174.70K

21.0%

BCRX BIOCRYST PHARMACEUTICALS INC

13 Nov 2025

Director

Sold on a plan

9,600

$68.54K

23.9%

BCRX BIOCRYST PHARMACEUTICALS INC

17 Jun 2024

Director

Sold at will

4,689

$28.13K

14.5%

BCRX BIOCRYST PHARMACEUTICALS INC

15 Jun 2023

Director

Sold at will

4,000

$31.92K

13.5%

4 decisions on file.